Molecular and Cellular Mechanisms of Selective Vulnerability in Neurodegenerative Diseases

The author highlight how recent methodological innovations — including single-cell transcriptomics, CRISPR-based screens, and human cell-based models of disease — are enabling new breakthroughs in our understanding of selective vulnerability.